• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

Introduction to (3-Bromo-6-methylpyridin-2-yl)methanamine (CAS No. 1060810-19-6)

(3-Bromo-6-methylpyridin-2-yl)methanamine, with the CAS number 1060810-19-6, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a brominated pyridine ring and a methyl group, making it a valuable intermediate in the synthesis of various bioactive molecules.

The chemical structure of (3-bromo-6-methylpyridin-2-yl)methanamine consists of a pyridine ring substituted with a bromine atom at the 3-position and a methyl group at the 6-position. The methanamine moiety attached to the pyridine ring imparts additional reactivity and functional versatility. This combination of substituents offers a wide range of synthetic opportunities, particularly in the development of novel pharmaceuticals and agrochemicals.

Recent advancements in synthetic chemistry have highlighted the importance of (3-bromo-6-methylpyridin-2-yl)methanamine as a key building block. Its reactivity and functional group compatibility make it an ideal candidate for various chemical transformations, including cross-coupling reactions, nucleophilic substitutions, and metal-catalyzed reactions. These reactions are crucial for the synthesis of complex molecules with potential therapeutic applications.

In the context of medicinal chemistry, (3-bromo-6-methylpyridin-2-yl)methanamine has been extensively studied for its role in the development of new drugs. One notable application is in the synthesis of inhibitors targeting specific enzymes and receptors involved in various diseases. For instance, research has shown that derivatives of this compound can exhibit potent inhibitory activity against kinases, which are key enzymes implicated in cancer progression and other proliferative disorders.

Additionally, (3-bromo-6-methylpyridin-2-yl)methanamine has been utilized in the synthesis of compounds with anti-inflammatory properties. Studies have demonstrated that certain derivatives can effectively modulate inflammatory pathways, making them promising candidates for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The versatility of (3-bromo-6-methylpyridin-2-yl)methanamine extends beyond medicinal chemistry into other areas such as materials science and catalysis. Its unique electronic properties make it suitable for use in the development of new materials with enhanced performance characteristics. For example, derivatives of this compound have been explored for their potential applications in organic electronics and photovoltaic devices.

In terms of safety and handling, it is important to note that while (3-bromo-6-methylpyridin-2-yl)methanamine is not classified as a hazardous material, standard laboratory safety protocols should be followed when working with this compound. Proper personal protective equipment (PPE) should be worn, and appropriate ventilation should be ensured to minimize exposure risks.

To summarize, (3-bromo-6-methylpyridin-2-yl)methanamine (CAS No. 1060810-19-6) is a valuable organic compound with a wide range of applications in medicinal chemistry, pharmaceutical research, and materials science. Its unique structural features and reactivity make it an essential building block for the synthesis of bioactive molecules and advanced materials. Ongoing research continues to uncover new possibilities for this compound, further solidifying its importance in modern scientific endeavors.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)